The Blunt Truth

APRIL 2, 2020

Of course, what’s happening in the cannabis world is what’s happening everywhere else: the coronavirus. Governor Kristi Noem has overcome her reluctance to allow any form of cannabis in her state, and signed a bill allowing the growth, production and transportation of hemp. DEA GUIDANCE. SOUTH DAKOTA.

DEA 101

DEA Hemp Packaging Recreational 101

SpeedWeed

AUGUST 16, 2021

Another iconic representative of the cannabis community, Charles Edward “Eddy” Lepp , has passed away after a battle with cancer. Army’s military intelligence unit in the Vietnam War from 1969–1972, and shortly after, became a lifelong fighter for cannabis rights. Eddy Lepp: A True Cannabis Crusader.

DEA 52

DEA Patients Therapy Cannabis 52

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . 30,000 patient doses) of MDMA in a four-step process beginning with a non-controlled starting material.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. MAPS continued to publish Bulletin articles about MDMA research , requests for donations , and discontinuing animal studies. submitted his first DEA application to manufacture marijuana for use in medical research. MAPS Founder Rick Doblin, Ph.D., Lyle Craker, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

NORML

SEPTEMBER 20, 2019

We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. Essentially, the federal government has monopolized cannabis research, and ElSohly’s product, according to some scientists who’ve seen it, is unsuitable for clinical trials.

DEA 230

DEA Research and Development Clinical Trials Patients 230